# 0409-5555-02 · Sodium Bicarbonate Injection · Hospira, Inc., a Pfizer Company — FDA drug shortage duration tracker

For 0409-5555-02 · Sodium Bicarbonate Injection · Hospira, Inc., a Pfizer Company, package ndc is 0409-5555-02; generic name is Sodium Bicarbonate Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Limited Availability, recorded from its source on 2026-09-01; source re-checked 2026-09-15.

- **Package NDC:** 0409-5555-02 _(verified: appears in the quote below)_
- **Generic name:** Sodium Bicarbonate Injection _(verified: appears in the quote below)_
- **Manufacturer:** Hospira, Inc., a Pfizer Company _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Limited Availability _(verified: appears in the quote below)_
- **FDA note:** Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay _(verified: appears in the quote below)_
- **Initial posting date:** 03/01/2017 _(verified: appears in the quote below)_
- **Last update date:** 08/24/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 3471 _(our reading, not quoted from the source)_
- **Reason for shortage:** Other _(verified: appears in its own passage below)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Endocrinology/Metabolism _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "03/01/2017", "package_ndc": "0409-5555-02", "generic_name": "Sodium Bicarbonate Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/24/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"

### Status

> "update_date": "08/24/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"

### Last update date

> "update_date": "08/24/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"

### Reason for shortage

> "update_date": "08/24/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"

### Dosage form

> "update_date": "08/24/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"

### Therapeutic category

> "update_date": "08/24/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-15. Review by: 2026-09-18.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).